Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2019 | Unmet needs in TTP

Paul Coppo • 13 Jun 2019
EHA 2019
Rare Diseases

The unmet needs in thrombotic thrombocytopenic purpura (TTP) are discussed here by Paul Coppo, MD, Saint-Antoine University Hospital, Paris, France, at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

More from Paul Coppo

Advances in the treatment and prognosis of TTP
2:41
Advances in the treatment and prognosis of TTP
Paul Coppo • 13 Jun 2019
Promising TTP treatments on the horizon
0:53
Promising TTP treatments on the horizon
Paul Coppo • 14 Jun 2019

Related Videos

Phase III CARES: survival and cardiovascular outcomes with anselamimab in cardiac AL amyloidosis
2:19
Phase III CARES: survival and cardiovascular outcomes with anselamimab in cardiac AL amyloidosis
Ashutosh Wechalekar • 9 Sep 2026
Managing solitary plasmacytomas: importance of accurate imaging and bone marrow assessment
1:39
Managing solitary plasmacytomas: importance of accurate imaging and bone marrow assessment
Elena Zamagni • 25 Sep 2026
Anselamimab in AL amyloidosis: combining and sequencing with plasma cell-directed treatment
2:14
Anselamimab in AL amyloidosis: combining and sequencing with plasma cell-directed treatment
Ashutosh Wechalekar • 9 Sep 2026
Phase III CARES subgroup analysis: signal of benefit with anselamimab in kappa AL amyloidosis
3:04
Phase III CARES subgroup analysis: signal of benefit with anselamimab in kappa AL amyloidosis
Ashutosh Wechalekar • 9 Sep 2026
The content of VJHemOnc is intended for healthcare professionals